News | Radiation Therapy | December 09, 2019

RaySearch Will Expand to New Headquarters in 2021

RaySearch Laboratories AB has experienced strong growth in recent years, creating the need for larger and more efficient premises. During the third quarter of 2021, the medical technology company will move its headquarters from Sveavägen 44 to a new location in Hagastaden in Stockholm, which is expected to become one of the world's leading life science hubs

RaySearch Laboratories AB (publ) has experienced strong growth in recent years, creating the need for larger and more efficient premises

December 9, 2019 — Karin Gedda, architect and interior designer, Strategisk Arkitektur, announced: "RaySearch is an innovative and high-performing software company that needs a work environment that strengthens and motivates its employees. Therefore, we have adapted the work environment to the business and its needs, which means many team and project rooms of different sizes for flexibility. In addition, there are several multifunctional areas and lounges for both work and recovery. With its own roof terrace, there is also the opportunity to look out over Stockholm and the leafy Brunnsviken area.”

Johan Löf, founder and CEO, RaySearch, said: “RaySearch is growing and, together with Strategisk Arkitektur, we have developed the concept for our new headquarters that reflects what RaySearch is and what we stand for. Health and a sustainable working life are also key themes. The new premises will support us in our continued relationships with customers and partners and will facilitate our continued expansion.”

The new RaySearch headquarters at Eugeniavägen 18 is a state-of-the-art office building designed by White Architects. It features a spectacular design with plenty of glass and a dark, slightly tilted facade. The building is environmentally certified and, with its distinct architectural expression, will be a landmark in Hagastaden.

The design concept focuses on the core values of RaySearch, such as innovation, consistently high quality, sustainability and long-term perspective, and the core of its business, to fight cancer through innovative software solutions. This is embodied in an environment of classic features (long-term) mixed with modern solutions (innovation), a peaceful and varied interior environment (sustainability) with an emphasis on high-quality natural materials, such as wood, stone and metal, many textiles for a cozy feel, and there are plenty of plants.

Lotta Larsson, HR Manager at RaySearch, said: “The goal is to create an inspiring and effective environment that supports our employees in their daily work. We want to promote the well-being and motivation of our employees and create an environment that stimulates innovation, collaboration and effective sharing of knowledge, as well as an active, sustainable and healthy lifestyle. On the basement level, for example, there will be shower and changing rooms for those who commute by bicycle, and, on the ground floor, there will be a gym. In addition, there are good opportunities for exercise, recovery and reflection in the natural environment of the nearby Haga Park.”

In and around Hagastaden, there is a large concentration of research and entrepreneurship in life science, a collective concept for sciences aimed at improving life and health. Here, world-leading education and research is conducted at the Karolinska Institute, the Royal Institute of Technology, Stockholm University and the Karolinska University Hospital. Half of the Stockholm region's life science companies are located within five kilometers of the area. The ambition is for Hagastaden to become one of the world's leading life science hubs.

For more information: www.raysearchlabs.com

Related Content

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
The "US Prostate Cancer Nuclear Medicine Diagnostics Market to 2027 - Country Analysis and Forecast by Type; PET Product" report has been added to ResearchAndMarkets.com's offering. The prostate cancer nuclear medicine diagnostics market in the US was valued at $194.47M in 2019 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach $431.76M by 2027.

Getty Images

News | Prostate Cancer | January 13, 2021
January 13, 2021 — The ...
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

News | Prostate Cancer | January 11, 2021
January 11, 2021 — A study
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.
Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions, announced that it has acquired Sun Nuclear Corporation. Sun Nuclear is the global leader in radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers around the world.
News | Quality Assurance (QA) | January 08, 2021
January 8, 2021 — Mirion Technologies, Inc., a global provider of
In this roundtable discussion hosted by ITN Editorial Director Melinda Taschetta-Millane, three medical experts will discuss the impact COVID-19 had on the industry in 2020, as well as projections for the industry in 2021.
Webinar | Coronavirus (COVID-19) | January 06, 2021
2020 was an unprecedented year, as the world grappled with a...
OptumInsight and Change Healthcare combine to advance a more modern, information and technology-enabled healthcare platform

Getty Images

News | Information Technology | January 06, 2021
January 6, 2020 — Optum, a diversified health services company and